UBS analyst Alice Nettleton initiates coverage on BioAge Labs Inc (NASDAQ: BIOA) with a Neutral rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage